Navigation Links
New drug proving effective in attacking advanced prostate cancer
Date:6/17/2013

INDIANAPOLIS, June 17, 2013 /PRNewswire-USNewswire/ -- Franciscan St. Francis Health Cancer Center today (June 17) is the first medical facility in Indiana to use a new drug to treat men with advanced prostate cancer.

It's called Xofigo®, a radiopharmaceutical used in patients with late-stage, metastatic disease that has spread to the bones. It recently was approved for use by the U.S. Food and Drug Administration.

As prostate cancer progresses to advanced stages it may become castration-resistant, which has become resistant to medical or surgical treatments that lower testosterone. About 90 percent of men with advanced prostate cancer will develop bone metastases.

"Most men with castration-resistant prostate cancer develop bone metastases, which can decrease overall survival," said Michael Eaton, MD, PhD, radiation oncologist, who performed the procedure. "Xofigo has actually demonstrated an ability to extend survival compared to existing treatment options."

Treatment is administered six times over a four-week period by intravenous injection. The drug binds with minerals in the bone to deliver radiation directly to bone tumors, limiting damage to the surrounding normal tissues.

"Treatment with Xofigo is well-tolerated by patients and results in minimal side effects," Eaton said. "It is encouraging to have a new treatment option for men."

Xofigo was developed by the Norwegian company Algeta ASA, in a partnership with Bayer.

According to the American Cancer Society, prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. About one in six will be diagnosed with it during his lifetime.

More than 238,000 new cases of prostate cancer will be diagnosed in 2013 with over 29,000 men dying from the disease, ACS predicts.

With hospitals in Indianapolis, Mooresville and Carmel, Franciscan St. Francis Health is a member of the Franciscan Alliance, one of the largest Catholic health care systems in the Midwest, with 13 hospitals throughout Indiana and Illinois. The Franciscan Alliance serves a geographic area with a population of 3.7 million people, provides care for more than 2.9 million outpatient visits and completes more than 100,000 inpatient discharges every year.

Contact:
Joe Stuteville
Media Relations Manager
317-528-7986 (o)
317-946-9930 (c)
317- 906-0079 (pager)
Joe.Stuteville@franciscanalliance.org


'/>"/>
SOURCE Franciscan St. Francis Health
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes
2. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
3. B. Braun Committed To Improving Patient Safety
4. New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
5. Treatment Adherence Emerging as Critical Theme in Improving Quality and Cost of US Healthcare
6. Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
7. Oncologists in the United States and Europe Indicate that Novel Chemotherapies Hold the Most Near-Term Promise for Improving Outcomes in Soft Tissue Sarcoma
8. Biometrics Limits Abuse while Improving Convenience
9. GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities
10. Mt. Airy Hospital Selects Sound Physicians - Leading Hospitalist Organization Focuses on Improving Quality and Reducing Cost of Inpatient Care
11. Frost & Sullivan: Improving Economies in Indonesia and Vietnam Present Strong Growth Potential in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):